Related Experiment Video
Updated: Aug 10, 2026
16:57
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
Published on: February 14, 2012
Metabolomics Analyses from Tissues in Parkinson's Disease
Fatema Bhinderwala1, Shulei Lei1, Jade Woods1
1Department of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, USA.
Methods in Molecular Biology (Clifton, N.J.)
|May 26, 2019
Summary
This study presents a detailed metabolomics workflow for neurological disorders like Parkinson's disease. It covers sample preparation, data analysis, and metabolite extraction for biomarker discovery and treatment assessment.
Area of Science:
- Neuroscience
- Biochemistry
- Analytical Chemistry
Background:
- Metabolomics aids in understanding neurological disorders, including Parkinson's disease, by identifying biomarkers and disease mechanisms.
- Challenges in metabolomics include sample preparation, metabolite extraction, and data analysis, which can impact results.
- Reproducible methods are crucial for accurate metabolomic investigations.
Purpose of the Study:
- To present a comprehensive metabolomics workflow for neurological and neurodegenerative disorder research.
- To detail a step-by-step protocol for sample preparation and metabolic analysis.
- To emphasize the importance of proper protocols for data collection, processing, and statistical analysis.
Main Methods:
- Detailed protocol for preparing neuronal cells and tissue samples for metabolomics.
- Metabolic analysis using nuclear magnetic resonance (NMR) and mass spectrometry (MS).
- Application of chemometrics and statistical methods for data interpretation.
Main Results:
- A standardized workflow addressing critical steps in metabolomics experiments.
- Methods for reproducible metabolite extraction and analysis.
- Guidelines for effective data processing and statistical analysis for biological insights.
Conclusions:
- The presented workflow enhances the reliability and reproducibility of metabolomics studies in neurological disorders.
- Proper methodology is essential for accurate biomarker identification and understanding disease progression.
- This approach supports the assessment of treatment outcomes in conditions like Parkinson's disease.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...